DrugPatentWatch Database Preview
VIVLODEX Drug Profile
» See Plans and Pricing
Which patents cover Vivlodex, and what generic alternatives are available?
Vivlodex is a drug marketed by Zyla and is included in one NDA. There are three patents protecting this drug and one Paragraph IV challenge.
This drug has seventeen patent family members in seventeen countries.
The generic ingredient in VIVLODEX is meloxicam. There are twenty-two drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the meloxicam profile page.
US ANDA Litigation and Generic Entry Outlook for Vivlodex
A generic version of VIVLODEX was approved as meloxicam by CIPLA on July 19th, 2006.
Summary for VIVLODEX
| International Patents: | 17 |
| US Patents: | 3 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 120 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for VIVLODEX |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for VIVLODEX |
| DailyMed Link: | VIVLODEX at DailyMed |
Pharmacology for VIVLODEX
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
US Patents and Regulatory Information for VIVLODEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zyla | VIVLODEX | meloxicam | CAPSULE;ORAL | 207233-001 | Oct 22, 2015 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| Zyla | VIVLODEX | meloxicam | CAPSULE;ORAL | 207233-002 | Oct 22, 2015 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Zyla | VIVLODEX | meloxicam | CAPSULE;ORAL | 207233-001 | Oct 22, 2015 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for VIVLODEX
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 107073010 | Start Trial |
| South Korea | 20170017915 | Start Trial |
| South Africa | 201700022 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
